共 50 条
- [41] Identification of 2-aminomethylphenol antimalarials with potent in vitro and in vivo activity against Plasmodium blood stagesABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250Heffernan, GavinJacobus, DavidKrasucki, PeterSaionz, KurtSchiehser, GuyShieh, Hong-MingZhao, WenyiAger, ArbaChavchich, MarinaBirrell, GeoffreyShanks, DennisEdstein, Michael
- [42] Discovery of novel cyclin-dependent kinase (CDK) and histone deacetylase (HDAC) dual inhibitors, with potent in vitro and in vivo anticancer activityEUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 189Cheng, ChunhuiYun, FanUllah, SadeeqYuan, Qipeng
- [43] First in human phase 1/2a study of PEN-221 somatostatin analog (SSA)-DM1 conjugate for patients (PTS) with advanced neuroendocrine tumor (NET) or small cell lung cancer (SCLC): Phase 1 results.JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Johnson, Melissa LynneMeyer, TimHalperin, Daniel M.Fojo, Antonio TitoCook, NatalieBlaszkowsky, Lawrence ScottSchlechter, Benjamin L.Yao, James C.Jemiai, YannisKriksciukaite, KristinaJones, MarshaEzema, NneamakaMei, LauraAlland, LeilaKulke, Matthew H.
- [44] Phenylthiazole Antibacterial Agents Targeting Cell Wall Synthesis Exhibit Potent Activity in Vitro and in Vivo against Vancomycin-Resistant EnterococciJOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (06) : 2425 - 2438Mohammad, HaroonYounis, WaleedChen, LuPeters, Christine E.Pogliano, JoePogliano, KitCooper, BruceZhang, JiananMayhoub, AbdelrahmanOldfield, EricCushman, MarkSeleem, Mohamed N.
- [45] Discovery of New Imidazo[2,1-b]thiazole Derivatives as Potent Pan-RAF Inhibitors with Promising In Vitro and In Vivo Anti-melanoma ActivityJOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (10) : 6877 - 6901Abdel-Maksoud, Mohammed S.El-Gamal, Mohammed, ILee, Bong S.El-Din, Mahmoud M. GamalJeon, Hong R.Kwon, DowAmmar, Usama M.Mersal, Karim, IAli, Eslam M. H.Lee, Kyung-TaeYoo, Kyung HoHan, Dong KeunLee, Jae KyunKim, GaramChoi, Hong SeokKwon, Young JikLee, Kwan HyiOh, Chang Hyun
- [46] Discovery of a Potent, Selective, and Orally Available MTHFD2 Inhibitor (DS18561882) with in Vivo Antitumor ActivityJOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (22) : 10204 - 10220Kawai, JunyaToki, TadashiOta, MasahiroInoue, HidekazuTakata, YoshimiAsahi, TakashiSuzuki, MakotoShimada, TakashiOno, KaoriSuzuki, KanaeTakaishi, SachikoOhki, HitoshiMatsui, SatoshiTsutsumi, ShinjiHirota, YasuhideNakayama, Kiyoshi
- [47] Discovery of Potent and Highly Selective Interleukin-2-Inducible T-Cell Kinase Degraders with In Vivo ActivityJOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (07) : 4979 - 4998Zhou, DanliZuo, YingyingPan, Zhengying
- [48] Potent in Vitro and In Vivo Efficacy of BYON4413, a Duba-Based Antibody-Drug Conjugate Targeting CD123 in Acute Myeloid LeukemiaBLOOD, 2023, 142van der Lee, Mirandavan Achtenberg, TanjaBrouwers-Vos, Annetvan der Vleuten, MoniqueKappers, WendyVerheijden, GijsHuls, Geert A.van Wigcheren, GlennUbink, RuudSesink, AloysMacInnes, AlysonSchuringa, Jan JacobDokter, Wim
- [49] Discovery of SMD-3040 as a Potent and Selective SMARCA2 PROTAC Degrader with Strong in vivo Antitumor ActivityJOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (15) : 10761 - 10781Yang, LinTu, WenbinHuang, LiyueMiao, BukeyanKaneshige, AtsunoriJiang, WeiLeng, LingyingWang, MeilinWen, BoSun, DuxinWang, Shaomeng
- [50] In vitro and in vivo activity of a novel c-Met-targeting antibody-drug conjugate using a DNA-alkylating, indolinobenzodiazepine payloadCANCER RESEARCH, 2017, 77Lai, Katharine C.Muvaffak, AsliLi, MinThemeles, MarianSikka, SurinaDonahue, KerryHicks, Stuart W.Romanelli, AngelaChittenden, Thomas